Ward et al., 2019), including muscular pain, nocturnal muscle cramping, weakness, rare rhabdomyolysis, and amyotrophic lateral sclerosis (ALS)-like muscle wasting conditions (Bai et al., 2021)
BPC-157 facilitates the development of organized tissue architecture at this interface, significantly improving functional recovery after surgeries such as rotator cuff or ACL repairs
Starting Dose: 0.25 mg (250 mcg) once daily Maintenance Dose: 0.25 to 0.5 mg daily, single or split dosing Duration: 4-6 weeks for acute injuries, 6-8 weeks for chronic issues Injection Site: Subcutaneous near injury site or abdominal fat for systemic Frequency: Once daily (some prefer twice daily split doses) Dosing frequency presents some flexibility
Unfortunately, in some conditions and diseases these parameters are impacted
Can Vital be used in younger patients or as a preventative treatment